I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2010
The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.
Epistemonikos ID: 7076bc767c1c303b1bb13e41042fa4001cb13c57
First added on: Jun 22, 2026